$11.56B
Revenue
$1.23B
Net Income
48.07%
Gross Margin
12.70%
Op. Margin
$2.37B
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
|---|---|---|---|---|
| Total Revenue | $3.67B | $2.84B | $2.68B | $2.36B |
| Revenue Growth % (YoY) | nan% | nan% | nan% | nan% |
| Cost of Revenue | $1.98B | $1.45B | $1.38B | $1.19B |
| Gross Profit | $1.69B | $1.39B | $1.30B | $1.17B |
| Gross Margin % | 46.1% | 48.9% | 48.6% | 49.5% |
| Operating Expenses | $1.06B | $1.05B | $1.01B | $966.00M |
| Research & Development | $390.00M | $375.00M | $394.00M | $377.00M |
| Operating Income | $631.00M | $343.00M | $291.00M | $203.00M |
| Operating Margin % | 17.2% | 12.1% | 10.9% | 8.6% |
| Other Income/Expense | $261.00M | $-35.00M | $788.00M | $-973.00M |
| Income Tax Expense | $149.00M | $44.00M | $173.00M | $-88.00M |
| Net Income | $743.00M | $264.00M | $906.00M | $-682.00M |
| Net Margin % | 20.2% | 9.3% | 33.8% | -28.9% |
| Basic EPS | 0.57 | 0.20 | 0.70 | -0.53 |
| Diluted EPS | 0.57 | 0.20 | 0.69 | -0.53 |
| Basic Shares Outstanding | - | 1.30B | 1.30B | 1.30B |
| Diluted Shares Outstanding | - | 1.31B | 1.31B | 1.30B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
|---|---|---|---|---|
| Cash & Cash Equivalents | $1.54B | $2.41B | $1.54B | $1.31B |
| Short-term Investments | $4.23B | $3.94B | $4.28B | $4.21B |
| Accounts Receivable | $500.00M | - | - | - |
| Inventory | $21.00M | - | - | - |
| Other Current Assets | $234.00M | $227.00M | $234.00M | $242.00M |
| Total Current Assets | $8.30B | $8.71B | $8.00B | $7.45B |
| Property Plant & Equipment | $53.00M | $51.00M | $46.00M | $46.00M |
| Goodwill | $491.00M | $491.00M | $491.00M | $491.00M |
| Intangible Assets | $30.00M | $33.00M | $36.00M | $39.00M |
| Long-term Investments | $975.00M | $676.00M | $831.00M | $894.00M |
| Other Non-current Assets | $39.00M | $23.00M | $28.00M | $23.00M |
| Total Assets | $15.19B | $15.04B | $14.56B | $13.40B |
| Deferred Revenue | $300.00M | $300.00M | $298.00M | $295.00M |
| Total Current Liabilities | $1.39B | $2.21B | $2.08B | $2.01B |
| Deferred Tax Liabilities | $55.00M | $29.00M | $36.00M | $5.00M |
| Common Stock | $10.38B | $10.12B | $9.98B | $9.83B |
| Retained Earnings | $2.86B | $2.12B | $1.85B | $947.00M |
| Total Stockholders Equity | $13.47B | $12.51B | $12.12B | $11.05B |
| Total Liabilities & Equity | $15.19B | $15.04B | $14.56B | $13.40B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
|---|---|---|---|---|
| Net Income | $743.00M | $264.00M | $224.00M | $-682.00M |
| Depreciation & Amortization | $7.00M | $8.00M | $16.00M | $8.00M |
| Operating Cash Flow | $725.00M | $513.00M | $795.00M | $367.00M |
| Capital Expenditure | $10.00M | $6.00M | $10.00M | $4.00M |
| Acquisitions | - | - | $56.00M | $56.00M |
| Purchases of Investments | $2.40B | $1.46B | $3.18B | $1.72B |
| Investing Cash Flow | $-654.00M | $335.00M | $-871.00M | $-619.00M |
| Financing Cash Flow | $-938.00M | $24.00M | $44.00M | $59.00M |
| Net Change in Cash | $-869.00M | $872.00M | $233.00M | $-189.00M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $2.84B | - | $7.88B | - |
| Cost of Revenue | $1.45B | - | $4.02B | - |
| Gross Profit | $1.39B | - | $3.86B | - |
| Operating Expenses | $1.05B | - | $3.02B | - |
| Research & Development | $375.00M | - | $1.15B | - |
| Operating Income | $343.00M | - | $837.00M | - |
| Other Income/Expense | $-35.00M | - | $-220.00M | - |
| Income Tax Expense | $44.00M | - | $129.00M | - |
| Net Income | $264.00M | - | $488.00M | - |
| Basic EPS | 0.20 | - | 0.38 | - |
| Diluted EPS | 0.20 | - | 0.37 | - |
| Basic Shares Outstanding | $1.30B | - | $1.30B | - |
| Diluted Shares Outstanding | $1.31B | - | $1.31B | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $2.41B | $1.50B |
| Short-term Investments | $3.94B | $3.98B |
| Other Current Assets | $227.00M | $209.00M |
| Total Current Assets | $8.71B | $7.25B |
| Property Plant & Equipment | $51.00M | $47.00M |
| Goodwill | $491.00M | $452.00M |
| Intangible Assets | $33.00M | $22.00M |
| Long-term Investments | $676.00M | $709.00M |
| Other Non-current Assets | $23.00M | $21.00M |
| Total Assets | $15.04B | $13.92B |
| Deferred Revenue | $300.00M | $283.00M |
| Total Current Liabilities | $2.21B | $1.96B |
| Deferred Tax Liabilities | $29.00M | $73.00M |
| Common Stock | $10.12B | $9.63B |
| Retained Earnings | $2.12B | $1.63B |
| Total Stockholders Equity | $12.51B | $11.56B |
| Total Liabilities & Equity | $15.04B | $13.92B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $264.00M | - | $488.00M | - |
| Depreciation & Amortization | $8.00M | - | $24.00M | - |
| Operating Cash Flow | $513.00M | - | $1.31B | - |
| Capital Expenditure | $6.00M | - | $16.00M | - |
| Acquisitions | - | - | $56.00M | - |
| Purchases of Investments | $1.46B | - | $4.64B | - |
| Investing Cash Flow | $335.00M | - | $-536.00M | - |
| Financing Cash Flow | $24.00M | - | $127.00M | - |
| Net Change in Cash | $872.00M | - | $916.00M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.